
Lasa Supergenerics Ltd is Rated Strong Sell
2026-08-06 10:10:42Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news articleWhen is the next results date for Lasa Supergenerics Ltd?
2026-08-05 23:20:09Lasa Supergenerics Ltd is scheduled to declare its results on 14 August 2026....
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-07-23 10:10:26Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis below reflects the stock’s current position as of 23 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-07-02 10:10:53Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-06-18 10:10:34Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 18 June 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read full news article
Lasa Supergenerics Ltd Locks at Lower Circuit With 3.7% Loss — Sellers Queue, No Buyers in Sight
2026-06-01 12:00:12At Rs 7.90, sellers were still queuing — but there were no buyers willing to take the other side. Lasa Supergenerics Ltd locked at its lower circuit of 5% on 1 Jun 2026, with unfilled sell orders and a frozen price.
Read full news article
Lasa Supergenerics Q4 FY26: Revenue Collapse Signals Critical Operational Crisis
2026-05-30 23:54:15Lasa Supergenerics Ltd., a micro-cap pharmaceutical manufacturer with a market capitalisation of ₹42.00 crores, reported catastrophic fourth-quarter results for FY26, with the company posting negative net sales of ₹0.13 crores and a net loss of ₹4.16 crores. The stock, trading at ₹8.30 as of May 29, 2026, has plummeted 42.24% over the past year and now trades 50% below its 52-week high of ₹16.60, reflecting investor exodus from what appears to be a company in severe operational distress.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-05-26 10:10:29Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Upper Circuit at Rs 8.38: Is Lasa Supergenerics Ltd’s 5% Surge Driven by Conviction or Thin Liquidity?
2026-05-25 11:00:55At Rs 8.38, the buying was done — not because demand dried up, but because the exchange wouldn't allow the stock to rise further. Lasa Supergenerics Ltd locked at its upper circuit of 5% on 25 May 2026, with buyers queuing and no sellers willing to part with shares.
Read full news articleBoard Meeting Intimation for The Quarter Ended June 302026
04-Aug-2026 | Source : BSELasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia; 1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026. 2. To discuss any other matter with the permission of the Chairperson.
Closure of Trading Window
29-Jun-2026 | Source : BSEClosure of trading window for the quarter ended June 30 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
30-May-2026 | Source : BSEAnnual Secretarial Compliance Report as on March 31st 2026
Corporate Actions
14 Aug 2026
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available






